David D Chang - Net Worth and Insider Trading
David D Chang Net Worth
The estimated net worth of David D Chang is at least $23 Million dollars as of 2024-06-01. David D Chang is the President and CEO of Allogene Therapeutics Inc and owns about 5,202,848 shares of Allogene Therapeutics Inc (ALLO) stock worth over $13 Million. David D Chang is also the EVP, R&D, Chief Medical Off. of Kite Pharma Inc and owns about 57,423 shares of Kite Pharma Inc (KITE) stock worth over $10 Million. Details can be seen in David D Chang's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David D Chang has not made any transactions after 2022-03-15 and currently still holds the listed stock(s).
Transaction Summary of David D Chang
David D Chang Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David D Chang owns 2 companies in total, including Allogene Therapeutics Inc (ALLO) , and Kite Pharma Inc (KITE) .
Click here to see the complete history of David D Chang’s form 4 insider trades.
Insider Ownership Summary of David D Chang
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALLO | Allogene Therapeutics Inc | 2022-03-15 | director & President and CEO |
| KITE | Kite Pharma Inc | 2017-10-03 | EVP & R&D & Chief Medical Off. |
David D Chang Latest Holdings Summary
David D Chang currently owns a total of 2 stocks. Among these stocks, David D Chang owns 5,202,848 shares of Allogene Therapeutics Inc (ALLO) as of March 15, 2022, with a value of $13 Million and a weighting of 55.65%. David D Chang also owns 57,423 shares of Kite Pharma Inc (KITE) as of September 25, 2017, with a value of $10 Million and a weighting of 44.35%.
Latest Holdings of David D Chang
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics Inc | 2022-03-15 | 5,202,848 | 2.49 | 12,955,092 |
| KITE | Kite Pharma Inc | 2017-09-25 | 57,423 | 179.79 | 10,324,081 |
Holding Weightings of David D Chang
David D Chang Form 4 Trading Tracker
According to the SEC Form 4 filings, David D Chang has made a total of 3 transactions in Allogene Therapeutics Inc (ALLO) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Allogene Therapeutics Inc is the sale of 23,648 shares on March 15, 2022, which brought David D Chang around $180,907.
According to the SEC Form 4 filings, David D Chang has made a total of 0 transactions in Kite Pharma Inc (KITE) over the past 5 years. The most-recent trade in Kite Pharma Inc is the sale of 7,927 shares on September 25, 2017, which brought David D Chang around $1 Million.
Insider Trading History of David D Chang
- 1
David D Chang Trading Performance
GuruFocus tracks the stock performance after each of David D Chang's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David D Chang is 3.67%. GuruFocus also compares David D Chang's trading performance to market benchmark return within the same time period. The performance of stocks bought by David D Chang within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David D Chang's insider trading performs compared to the benchmark.
Performance of David D Chang
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.11 | | | | | |
| Relative Return to S&P 500(%) | 0.64 | | | | | |
David D Chang Ownership Network
David D Chang Owned Company Details
What does Allogene Therapeutics Inc do?
Who are the key executives at Allogene Therapeutics Inc?
David D Chang is the director & President and CEO of Allogene Therapeutics Inc. Other key executives at Allogene Therapeutics Inc include director & 10 percent owner Arie Belldegrun , CHIEF FINANCIAL OFFICER Geoffrey M. Parker , and GENERAL COUNSEL Earl Martin Douglas .
Allogene Therapeutics Inc (ALLO) Insider Trades Summary
Over the past 18 months, David D Chang made no insider transaction in Allogene Therapeutics Inc (ALLO). Other recent insider transactions involving Allogene Therapeutics Inc (ALLO) include a net sale of 11,602 shares made by Veer Bhavnagri , a net purchase of 1,724,137 shares made by Arie Belldegrun , and a net sale of 18,640 shares made by Deborah M. Messemer .
In summary, during the past 3 months, insiders sold 0 shares of Allogene Therapeutics Inc (ALLO) in total and bought 1,724,137 shares, with a net purchase of 1,724,137 shares. During the past 18 months, 40,242 shares of Allogene Therapeutics Inc (ALLO) were sold and 1,724,327 shares were bought by its insiders, resulting in a net purchase of 1,684,085 shares.
Allogene Therapeutics Inc (ALLO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Allogene Therapeutics Inc Insider Transactions
David D Chang Mailing Address
Above is the net worth, insider trading, and ownership report for David D Chang. You might contact David D Chang via mailing address: C/o Allogene Therapeutics, Inc., 210 East Grand Avenue, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
